EnWave Corporation

EnWave Corporation

March 22, 2011 08:30 ET

EnWave Begins Testing Continuous Pilot-Scale powderREV™ Dehydration Technology

VANCOUVER, BRITISH COLUMBIA--(Marketwire - March 22, 2011) - EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave", or the "Company") announced today that the Company has started testing initial materials on the continuous pilot-scale version of its powderREV™ dehydration technology that it is developing in collaboration with one of the Company's multi-national partners, Danisco AS. powderREV™ is designed to dehydrate a continuous stream of frozen biomaterials at significantly higher speed and lower cost than the standard industrial method of tray freeze drying.

"We are very excited to begin testing this scaled-up version of powderREV™," stated Dr. Tim Durance, Chairman and Co-CEO of EnWave. "This is brand new technology for the processing sector, and today we took a big step forward in our goal to introduce Radiant Energy Vacuum as a new standard for high quality bulk powder drying."

Since July 2008, EnWave has been collaborating with Danisco, a leading global producer of probiotics and food cultures, on the development of a commercial-scale Radiant Energy Vacuum ("REV") dehydration process. Since that time, the project has progressed from early-stage proof-of-concept through to demonstration prototype, and now into the continuous pilot-scale stage. EnWave plans to complete internal testing on the technology prior to conducting a full validation with Danisco's scientists and engineers.

If the validation is successful, the Company plans to ship the machine to a Danisco pilot facility for a final operational evaluation. Ultimately, the goal is to sign a licence and royalty agreement for a commercial-scale machine once the pilot-scale technology has been successfully tested and its cost effectiveness demonstrated.

About Danisco

With a rich and innovative portfolio, Danisco is a world leader in food ingredients, enzymes and bio-based solutions. Using nature's own materials, science and the knowledge of our 6,800 people, we design and deliver bio-based ingredients that meet market demand for healthier and safer products. Danisco's ingredients are used globally in a wide range of industries — from bakery, dairy and beverages to animal feed, laundry detergents and bioethanol — to enable functional, economic and sustainable solutions. Headquartered in Denmark and operating from more than 80 locations, Danisco's key focus is to become our customers' First choice and a truly market-driven global business. Find out more at www.danisco.com.

About EnWave

Using proprietary technologies developed in conjunction with the University of British Columbia, EnWave is commercializing a new method for dehydrating food and biological materials using Radiant Energy Vacuum ("REV") technology under its nutraREV™, powderREV™, quantaREV™, bioREV™, freezeREV™ and MIVAP™ brands. REV technology combines microwave energy transfer under vacuum to dehydrate and alter structures and drive chemical reactions, thereby creating unique product characteristics for both food products and medical applications that include fruit, vegetables, probiotics, enzymes, proteins, food cultures, vaccines and antibodies. More information about EnWave is available at www.enwave.net.

EnWave Corporation

Dr. Tim Durance, Chairman & Co-CEO

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. There is no guarantee that the Company's REV technology can or will improve processes in the target industry; even if the Company's REV technology can be used as described in this document, there is no guarantee that such use will result in orders for the Company's REV technology.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information